evoke trial semaglutide A Critical Appraisal of the and Evoke+ trials for Alzheimer's disease SELECT Trial

Changes in your appetite with semaglutide depend on your dosage, metabolism, and underlying conditions

Cases of early-onset colorectal cancer (EOCRC) have risen alarmingly since the 1990s, alongside a surge in metabolic diseases, particularly obesity and type 2 diabetes mellitus (T2DM), among young populations

Starting at $250

Its your daily secret to navigating a busy schedule while maintaining your natural spark

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field

Discover smell sensitivity, and what to do if GLP1s like Ozempic, Wegovy, or Mounjaro have altered your sense of smell.